CLOSE X

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE2431.40113.4 (+4.89 %)
PREV CLOSE ( ) 2318.00
OPEN PRICE ( ) 2303.05
BID PRICE (QTY) 2431.25 (24)
OFFER PRICE (QTY) 2433.15 (25)
VOLUME 59930
TODAY'S LOW / HIGH ( )2302.30 2437.00
52 WK LOW / HIGH ( )1909.9 2670
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 03-07 1991
Management Info
Ramesh Juneja - Chairman Rajeev Juneja - Managing Director
Registered Office

Address 208,Okhla Industrial Estate,Phase - 111,
New Delhi,
Delhi-110020

Phone 011-46846700 / 47476600

Email contact@mankindpharma.com

Website www.mankindpharma.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
02Sep Mankind Pharma gains on BSE
Mankind Pharma is currently trading at Rs. 2372.00, up by 12.00 points o..
01Sep Mankind Pharma sells 100% stake in Bro
Mankind Pharma has sold its 100% stake held in Broadway Hospitality Serv..
20Aug Mankind Pharma inks pact with China’s
Mankind Pharma has entered into an exclusive in-licensing and marketing..
19Aug Mankind Pharma informs about newspaper
In furtherance to its intimation dated August 18, 2026, with regard to t..
14Aug Mankind Pharma incorporates wholly own
Mankind Pharma has incorporated wholly owned subsidiary (WOS) under the..
Financials
Rs. in Millions
QTR Jun 26 ANNUAL 26
Net Profit5584.920375.6
Gross Profit 7565.7 23150
Operating Profit 9625.434120.2
Net Sales 29640.5104211.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Kwality Pharma (BSE)
 3773.95 (8.59%)
M.Cap ( in Cr)3906.28
Torrent Pharma (BSE)
 4967.05 (3.39%)
M.Cap ( in Cr)188757.55
Wockhardt (BSE)
 2181.00 (4.51%)
M.Cap ( in Cr)35472.04
Concord Biotech (BSE)
 1585.00 (6.10%)
M.Cap ( in Cr)16366.68
Glenmark Pharma. (BSE)
 2462.65 (3.47%)
M.Cap ( in Cr)69645.99
Shareholding Pattern
PROMOTERS 72.63%
MUTUAL FUNDS/UTI 10.87%
NON-INSTITUTION 2.57%
FI/BANKS/INSURANCE 1.54%
GOVERNMENT 0%
FII 0%
Advisory for Investors Complaints Data August 2026 Broking Complaints Data August 2026 DP

Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & quick

  • > Register On SCORES / SMARTODR Portal
  • > Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
  • > Benefits:
    • Effective communication
    • Speedy Redressal of Grievance / Dispute
  • http://scores.sebi.gov.in
  • https://smartodr.in/login
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002
  • 6)Verified UPI ID for receiving Payments: badjate.rzp1.brk@validhdfc
  • 7)Click here for QR Code

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.